Jennifer N. Hogan

The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model

R. Fucini, W. Flanagan, M. Ballinger, 2009, Molecular Cancer Therapeutics.

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo

R. Fucini, A. Howlett, Brian J. Belmont, 2010, Cancer Chemotherapy and Pharmacology.